GLOBRYTE: A Phase III, Open-Label, Multicenter, Randomized Trial Evaluating Glofitamab Monotherapy in Patients with Relapsed or Refractory Mantle Cell Lymphoma

被引：5

作者：

Phillips, Tycel J. ^{[1
]}

Matasar, Matthew ^{[2
]}

Eyre, Toby A. ^{[3
]}

Gine, Eva ^{[4
]}

De L'Etang, Audrey Filezac ^{[5
]}

Byrne, Ben ^{[6
]}

Lundberg, Linda ^{[5
]}

Padovani, Alejandra ^{[5
]}

Boetsch, Christophe ^{[5
]}

Bottos, Alessia ^{[5
]}

Qayum, Naseer ^{[6
]}

机构：

[1] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA

[2] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA

[3] Oxford Univ Hosp NHS Fdn Trust, Churchill Canc Ctr, Oxford, England

[4] Hosp Clin Barcelona, Barcelona, Spain

[5] F Hoffmann La Roche Ltd, Basel, Switzerland

[6] Roche Prod Ltd, Welwyn Garden City, Herts, England

来源：

关键词：

D O I：

10.1182/blood-2023-173946

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4